Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like Biogen To Present Data At July 13, 2017 FDA Panel Unanimously Endorses Novartis AG's CAR-T Leukemia Drug July 12, 2017 Johnson & Johnson Employee Pleads With CEO, Lawmakers to Help Save DACA January 11, 2018
